O3 TP53-mutated Endometrial Cancers and Associations with Race and Survival Outcomes

Karley Whelan,Samantha Thomas,Bhavana Pothuri,Victoria Bae-Jump,Lindsay Borden,Premal Thaker,Paulina Haight,Rebecca Arend,Emily Ko,Amanda Jackson,Bradley Corr,Gottfried Konecny,Jason Wright,Linda Duska,Mairead Dillon,Michelle Lightfoot,Meredith Newton,Christina Washington, Margaret Mullen,Casey Cosgrove, Adrian Horsono, Kristina Powell, Thomas Herzog, Ritu Salani, Angeles Alvarez Secord

Gynecologic oncology（2023）

引用 0|浏览38

暂无评分

摘要

This multi-center Endometrial Cancer Molecularly Targeted Therapy Consortium (ECMT2) study of a real-world population investigated the association between race, TP53 mutations, histologic subtype, and prevalence of comorbidities to better elucidate the etiology of disparate survival outcomes between Black and White patients with endometrial cancer (EC).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要